Insulet | PODD - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Abbott USD 3.6B 330M 2026-06
Align Technology USD 462.67M 2.67M 2026-06
AtriCure USD 82.56M 1.99M 2026-06
Baxter International USD 735M 7M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Boston Scientific USD 1.8B 22M 2026-06
Cardinal Health USD 1.51B 6M 2026-03
Cooper Companies USD 676.2M 303.1M 2026-03
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Eli Lilly USD 3.43B 496M 2026-06
Globus Medical USD 286.82M 10.95M 2026-06
ICU Medical USD 151.92M 2.64M 2026-06
Inogen USD 43.77M 510K 2024-06
Insulet USD 344.8M 27.6M 2026-06
Integra LifeSciences USD 166.22M 12.01M 2026-06
J&J USD 6.42B 381M 2026-06
Medtronic 2.96B 9M 2025-12
Merit Medical Systems USD 129.23M 18.76M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Solventum Corp USD 927M 144M 2026-06
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 111.64M 3.45M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
West Pharmaceutical Services USD 117.6M 18.1M 2026-06
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06